Quercetin alleviates hyperoxia-induced bronchopulmonary dysplasia by inhibiting ferroptosis through the MAPK/PTGS2 pathway: Insights from network pharmacology, molecular docking, and experimental evaluations | Literature Database for Quercetin, Rutin, Isorhamnetin, and Their Related Compounds | Alps Pharmaceutical Ind. Co.,Ltd.

Literature Database for Quercetin, Rutin, Isorhamnetin, and Their Related Compounds

Quercetin alleviates hyperoxia-induced bronchopulmonary dysplasia by inhibiting ferroptosis through the MAPK/PTGS2 pathway: Insights from network pharmacology, molecular docking, and experimental evaluations

Authors:: Xianhui Deng; Dan Chen; Anni Xie; Shengpeng Li; Ailing Chen; Qin Zhou; Renqiang Yu

Reference:: Chemical Biology & Drug Design; 2024; 103; e14520

DOI:: 10.1111/cbdd.14520

See Abstract

Key Words:: Bronchopulmonary dysplasia; quercetin; network pharmacology; MAPK/PTGS2; ferroptosis; molecular docking

Back to index